SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-17-000465
Filing Date
2017-06-23
Accepted
2017-06-23 20:17:48
Documents
1
Period of Report
2017-06-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 5664
  Complete submission text file 0000904454-17-000465.txt   7790
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Issuer) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address LIKHACHEVSKY DRIVE 5 "B" DOLGOPRUDNY 1Z 141701
Business Address LIKHACHEVSKY DRIVE 5 "B" DOLGOPRUDNY 1Z 141701 7 495 970 0032
Public Joint Stock Co Pharmstandard (Reporting) CIK: 0001598754 (see all company filings)

State of Incorp.: 1Z | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35443 | Film No.: 17928754

Mailing Address 10A, RUE HENRI SCHNADT LUXEMBOURG N4 L-2530
Business Address 10A, RUE HENRI SCHNADT LUXEMBOURG N4 L-2530 352 24840131
Pharmstandard International S.A. (Reporting) CIK: 0001598762 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35443 | Film No.: 17928755